SCHEMBL9108510

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL9889697	0.89	LYN (0.39)	CNR2MAPTPTGDR
	SCHEMBL9103617	0.89	PLA2G7 (0.42)	SCN9ATTBK1LTA4HEPHX2
	SCHEMBL9105930	0.87	FABP4 (0.38)	CSF1RSCN9AALDH1A1POLBL3MBTL1
	SCHEMBL9101618	0.87	PLA2G7 (0.41)	CSF1RCNR2PTGDR
	SCHEMBL9106828	0.87	PLA2G7 (0.48)	CNR2
	SCHEMBL9107940	0.86	PLAAT3 (0.42)	CSF1RSCN9AMAPT
	SCHEMBL9109999	0.86	CNR2 (0.40)	CNR2
	SCHEMBL9103212	0.84	CYP3A4 (0.42)	PTGDR
	SCHEMBL9889714	0.83	LMNA (0.37)	CNR2ALDH1A1MAPTPTGDR
	SCHEMBL9106932	0.82	AURKA (0.35)	SCN9ACACNA1BTTBK1LTA4HEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.